SCHEMBL6087480

SCHEMBL6087480

Nc1cnn(-c2cc(C(F)(F)F)cc(C(F)(F)F)n2)c1N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.34
IRAK4 Q9NWZ3 5/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
MAPT P10636 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
XDH P47989 1/20 0.31
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
GABRA1 P14867 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6088816 0.85 NPC1 (0.38) SLC2A1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6088510 0.84 SLC2A1 (0.47) SLC2A1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6087521 0.72 SMN1; SMN2 (0.56) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL6088231 0.72 ALDH1A1 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1IRAK4
SCHEMBL6088012 0.69 POLB (0.36) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL6087341 0.69 NPC1 (0.34) NPC1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL3291350 0.68 CES2 (0.44) HPGDALDH1A1HSP90AA1HSP90AB1CYP3A4
SCHEMBL2479769 0.67 NOS3 (0.47) ALDH1A1HSP90AA1HSP90AB1MAPTKMT2A
SCHEMBL11092214 0.64 PTGS1 (0.44) RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL10670241 0.64 GABRB3 (0.54) SMN1; SMN2CYP3A4GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7056354-B2 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibers L'OREAL (FR) 2006-06-06 US claimed
US-20040255397-A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers L'OREAL (FR) 2004-12-23 US claimed
EP-1412348-A1 COMPOUNDS DERIVED FROM DIAMINOPYRAZOLE SUBSTITUTED BY A HETEROAROMATIC RADICAL AND THEIR USE IN OXIDATION DYEING OF KERATINOUS FIBRES L'OREAL (FR) 2004-04-28 EP claimed
WO-2003008405-A1 COMPOUNDS DERIVED FROM DIAMINOPYRAZOLE SUBSTITUTED BY A HETEROAROMATIC RADICAL AND THEIR USE IN OXIDATION DYEING OF KERATINOUS FIBRES L'OREAL (FR) 2003-01-30 WO claimed
US-7056354-B2 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibers L'OREAL (FR) 2006-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040255397-A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers KRT18, AOC1, XRCC5 SLC2A1 4604/4885NPC1 4634/4885RAB9A 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.